Dayton, Ohio 45405

  • Hiatal Hernia


Prospective, single-arm, open-label study to evaluate re-occurrence and quality of life in subjects undergoing primary Hiatal hernia repair using SurgiMend biological mesh. Up to 15, with a target of 10, subjects are planned to be enrolled at one site. All subjects will receive the SurgiMend mesh during surgery. Data collected will be compared to historical data. Subjects will complete a pre-operative visit. After surgery, in addition to any standard of care visits, subjects will complete 3- and 6-month follow-ups involving a phone QOL survey and will have an upper GI series at 6 months.


Inclusion Criteria: - Diagnosis of type 3 or 4 hiatal hernia (8) - Subject is able to give informed consent - Adults at least 18 years of age Exclusion Criteria: - Currently pregnant - Prior hiatal hernia repair - Prior gastric surgery - Prior foregut surgery - Known esophageal dysfunction or dysmotility - Cirrhosis or ascites - Known malignancy - Known allergy to biologic mesh - Known allergy to barium or other contrast material used in UGI - Religious objection to animal implant - Cognitive impairment - Prisoners



Primary Contact:

Principal Investigator
Paul Levy, DO
Kettering Health Network

Paul Levy, DO
Phone: 937-298-4331

Backup Contact:

Allison Dymacek, MACPR, BSN
Phone: 937-395-8367

Location Contact:

Dayton, Ohio 45405
United States

Paul Levy, DO

Site Status: Recruiting

Data Source:

Date Processed: December 07, 2022

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.